Literature DB >> 27767253

Blood pressure in patients with atrial fibrillation: part 2-treatment.

Debbie L Cohen1, Raymond R Townsend1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27767253      PMCID： PMC8030848          DOI： 10.1111/jch.12939

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN： 1524-6175            Impact factor:   3.738


× No keyword cloud information.
  25 in total

1.  Meta-analysis: inhibition of renin-angiotensin system prevents new-onset atrial fibrillation.

Authors:  Kishlay Anand; Aryan N Mooss; Tom T Hee; Syed M Mohiuddin
Journal:  Am Heart J       Date:  2006-08       Impact factor: 4.749

2.  Selective aldosterone blockade suppresses atrial tachyarrhythmias in heart failure.

Authors:  Sunil C Shroff; Kyungmoo Ryu; Nichole L Martovitz; Brian D Hoit; Bruce S Stambler
Journal:  J Cardiovasc Electrophysiol       Date:  2006-05

Review 3.  Hypertension and atrial fibrillation: diagnostic approach, prevention and treatment. Position paper of the Working Group 'Hypertension Arrhythmias and Thrombosis' of the European Society of Hypertension.

Authors:  Athanasios J Manolis; Enrico Agabiti Rosei; Antonio Coca; Renata Cifkova; Serap E Erdine; Sverre Kjeldsen; Gregory Y H Lip; Krzysztof Narkiewicz; Gianfranco Parati; Josep Redon; Roland Schmieder; Costas Tsioufis; Giuseppe Mancia
Journal:  J Hypertens       Date:  2012-02       Impact factor: 4.844

4.  Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study.

Authors:  Rajeev K Pathak; Melissa E Middeldorp; Dennis H Lau; Abhinav B Mehta; Rajiv Mahajan; Darragh Twomey; Muayad Alasady; Lorraine Hanley; Nicholas A Antic; R Doug McEvoy; Jonathan M Kalman; Walter P Abhayaratna; Prashanthan Sanders
Journal:  J Am Coll Cardiol       Date:  2014-11-24       Impact factor: 24.094

5.  Use of metoprolol CR/XL to maintain sinus rhythm after conversion from persistent atrial fibrillation: a randomized, double-blind, placebo-controlled study.

Authors:  V Kühlkamp; A Schirdewan; K Stangl; M Homberg; M Ploch; O A Beck
Journal:  J Am Coll Cardiol       Date:  2000-07       Impact factor: 24.094

6.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

7.  Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs.

Authors:  Shu-sen Yang; Wei Han; Hong-yan Zhou; Guo Dong; Bai-chun Wang; Hong Huo; Na Wei; Yong Cao; Guo Zhou; Chun-hong Xiu; Wei-min Li
Journal:  Chin Med J (Engl)       Date:  2008-01-05       Impact factor: 2.628

8.  Prevention of atrial fibrillation onset by beta-blocker treatment in heart failure: a meta-analysis.

Authors:  Imad Abi Nasr; Anissa Bouzamondo; Jean-Sébastien Hulot; Olivier Dubourg; Jean-Yves Le Heuzey; Philippe Lechat
Journal:  Eur Heart J       Date:  2007-02-08       Impact factor: 29.983

9.  Angiotensin-converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation.

Authors:  Philippe L L'Allier; Anique Ducharme; Pierre-Frédéric Keller; Holly Yu; Marie-Claude Guertin; Jean-Claude Tardif
Journal:  J Am Coll Cardiol       Date:  2004-07-07       Impact factor: 24.094

10.  Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study.

Authors:  E J Benjamin; D Levy; S M Vaziri; R B D'Agostino; A J Belanger; P A Wolf
Journal:  JAMA       Date:  1994-03-16       Impact factor: 56.272
View more
  3 in total

1.  Association of Oral Anticoagulants and Verapamil or Diltiazem With Adverse Bleeding Events in Patients With Nonvalvular Atrial Fibrillation and Normal Kidney Function.

Authors:  Phuong Pham; Stephan Schmidt; Lawrence Lesko; Gregory Y H Lip; Joshua D Brown
Journal:  JAMA Netw Open       Date:  2020-04-01

2.  Risk factor management of atrial fibrillation using mHealth: The Atrial Fibrillation - Helping Address Care with Remote Technology (AF-HEART) Pilot Study.

Authors:  Lindsey R Mitrani; Isaac Goldenthal; Jamie Leskowitz; Elaine Y Wan; Jose Dizon; Deepak Saluja; Ruth Masterson Creber; Megan Reading Turchioe; Robert R Sciacca; Hasan Garan; Kathleen T Hickey; Judith Korner; Angelo B Biviano
Journal:  Cardiovasc Digit Health J       Date:  2021-11-24

Review 3.  Efficacy of treatment methods for uncontrolled hypertension and its effects on atrial fibrillation: A systematic narrative review.

Authors:  Abdulaziz A Alodhayani; Abdullah Alkhushail; Mashhor Alhantoushi; Saad M Alsaad; Turky H Almigbal; Khalid Alotaibi; Mohammed A Batais; Abdulrahman Altheaby; Sultan Al Dalbhi; Yasser Alghamdi
Journal:  Int J Health Sci (Qassim)       Date:  2019 Nov-Dec
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.